AquaBounty Technologies Stock Forecast, Price & News

AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

Is AquaBounty Technologies a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies or view top-rated stocks.

How has AquaBounty Technologies' stock price been impacted by Coronavirus?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AQB shares have decreased by 2.7% and is now trading at $1.80.
View which stocks have been most impacted by COVID-19.

Are investors shorting AquaBounty Technologies?

AquaBounty Technologies saw a decline in short interest in November. As of November 30th, there was short interest totaling 2,960,000 shares, a decline of 17.5% from the November 15th total of 3,590,000 shares. Based on an average trading volume of 1,170,000 shares, the short-interest ratio is presently 2.5 days. Currently, 4.6% of the company's shares are short sold.
View AquaBounty Technologies' Short Interest.

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 8th 2022.
View our earnings forecast for AquaBounty Technologies.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) issued its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.03. The firm earned $0.46 million during the quarter, compared to analyst estimates of $0.76 million. AquaBounty Technologies had a negative net margin of 2,764.14% and a negative trailing twelve-month return on equity of 11.24%.
View AquaBounty Technologies' earnings history.

What price target have analysts set for AQB?

4 Wall Street analysts have issued 12-month target prices for AquaBounty Technologies' shares. Their forecasts range from $4.50 to $15.00. On average, they anticipate AquaBounty Technologies' share price to reach $8.13 in the next year. This suggests a possible upside of 351.4% from the stock's current price.
View analysts' price targets for AquaBounty Technologies or view top-rated stocks among Wall Street analysts.

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:

• Sylvia A. Wulf, President, Chief Executive Officer & Director
• Alejandro Rojas, Chief Operating Officer
• David A. Frank, Chief Financial Officer & Treasurer
• Mark Walton, Chief Technology Officer
• David F. Melbourne, Chief Commercial Officer

Who are some of AquaBounty Technologies' key competitors?

Some companies that are related to AquaBounty Technologies include 4D Molecular Therapeutics (FDMT), Inventiva (IVA), Inventiva (IVA), Consort Medical plc (CSRT.L) (CSRT), BioXcel Therapeutics (BTAI), Graphite Bio (GRPH), IRadimed (IRMD), Relmada Therapeutics (RLMD), The Pennant Group (PNTG), Personalis (PSNL), Lexicon Pharmaceuticals (LXRX), HLS Therapeutics (HLS), POINT Biopharma Global (PNT), SIGA Technologies (SIGA) and Beximco Pharmaceuticals (BXP).
View all of AQB's competitors.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Cutler Group LP (0.00%). Company insiders that own AquaBounty Technologies stock include Alana Kirk, David A Frank, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends for AquaBounty Technologies.

Which institutional investors are selling AquaBounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for AquaBounty Technologies or view top insider-selling stocks.

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $1.80.

How much money does AquaBounty Technologies make?

AquaBounty Technologies has a market capitalization of $127.85 million and generates $130 thousand in revenue each year. The company earns $-16.40 million in net income (profit) each year or ($0.37) on an earnings per share basis.

How many employees does AquaBounty Technologies have?

AquaBounty Technologies employs 72 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

Where are AquaBounty Technologies' headquarters?

AquaBounty Technologies is headquartered at 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at (978) 648-6000 or via email at [email protected].